Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Swietlik (Cambridge, United Kingdom), P. Ghataorhe (London, United Kingdom), K. Zalewska (Cardiff, United Kingdom), J. Wharton (London, United Kingdom), L. Howard (London, United Kingdom), D. Taboada (Cambridge, United Kingdom), J. Cannon (Cambridge, United Kingdom), N. Morrell (Cambridge, United Kingdom), M. Wilkins (London, United Kingdom), M. Toshner (Cambridge, United Kingdom), J. Pepke-Zaba (Cambridge, United Kingdom), C. Rhodes (London, United Kingdom). Plasma metabolomics in chronic thromboembolic pulmonary hypertension. 1552

Member's Comments

No comment yet.

Related content which might interest you: Plasma metabolomics exhibit response to therapy in chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 57 (4) 2003201; 10.1183/13993003.03201-2020 Year: 2021 Platelets and chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Haemodynamics and chronic thromboembolic pulmonary hypertension Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – State of the art session: Pulmonary vascular diseases Year: 2018 Chronic thromboembolic pulmonary hypertension Source: International Congress 2015 – ME5 Chronic thromboembolic pulmonary hypertension Year: 2015 Chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (1) 1801915; 10.1183/13993003.01915-2018 Year: 2019 Chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Russian Programme 2017 Year: 2017 Evaluation of serum cytokines in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension with hypercholesterolemia Source: International Congress 2017 – PAH and CTEPH Year: 2017 Genetic diagnostics in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2019 – Novel methods, diagnostics and biomarkers in chronic lung diseases Year: 2019 Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 53 (6) 1802004; 10.1183/13993003.02004-2018 Year: 2019 Diagnosis of chronic thromboembolic pulmonary hypertension Source: Eur Respir Rev 2017; 26: 160108 Year: 2017 Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology Source: Eur Respir Rev 2009; 19: 59-63 Year: 2010 A roadmap for management of chronic thromboembolic pulmonary hypertension Source: Eur Respir J, 54 (4) 1901295; 10.1183/13993003.01295-2019 Year: 2019 Peculiarities of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 236s Year: 2002 Chronic thromboembolic pulmonary hypertension at the crossroad Source: Eur Respir J 2014; 43: 1230-1232 Year: 2014 Vasodilator treatment in chronic thromboembolic pulmonary hypertension Source: Annual Congress 2003 - Update on chronic thromboembolic pulmonary hypertension Year: 2003 Incidence of chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism Year: 2011 Fibrinogen AaThr312Ala polymorphism predisposes to chronic thromboembolic pulmonary hypertension Source: Annual Congress 2007 - Acute and chronic pulmonary embolism Year: 2007 Platelet function in patients with chronic thromboembolic pulmonary hypertension Source: Annual Congress 2009 - Acute and chronic venous thromboembolic disease Year: 2009 Pulmonary function in patients with idiopathic pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension Source: Annual Congress 2010 - Pulmonary circulation I Year: 2010